: A kinome siRNA screen identifies regulators of G2/M progression in ovarian cancer. Figure S1 shows the correlation between replicates in the screen. Table S1 (excel file) reports the mean ploidy indices for each gene in the screen. Table S2 (excel file) reports the mean ploidy indices, gene names and accession numbers of the 25 identified hits from the screen. Table S3 (excel file) reports the sequences of all siRNAs used in the screen. Figure S4 describes the centrosome engagement/disengagement cycle in SKOv3 cells and provides further controls to support the notion that C-Nap1 is a target for phosphorylation by SIK2 in the centrosome. Figure S7 shows the paradoxical effect of reducing early paclitaxel-induced apoptosis. Table S4 reports the coefficients of correlations between each of the proteins measured by Reverse Phase Protein Arrays and the magnitude of inhibition of proliferation of ovarian cancer cells following KD of SIK2 using three different siRNAs in three ovarian cancer cell lines. A)-The 779 siRNA pools used in the screen were divided into three plates (320 pools for plates 1 and 2 and 139 pools in plate 3) and three replicates were used for each plate. Shown in the lower diagonal of each plot are dot plots representing the correlation between the ploidy indices for each pair of the three replicates used per plate. The corresponding Pearson correlation coefficient for each pair is shown in the upper diagonal of each plot. Although replicate 3 in the first plate shows lower than expected correlation with other replicates, its inclusion in the analysis has not significantly changed the cut-off for this plate as the median of all three replicates was chosen for calculating the cut-off rather than the mean. A) The log2 expression levels of the 4 affymetrix probe sets (platform U 133A Plus 2.0 ) representing SIK2 in 229 ovarian cancers are shown. Probe set 215752_at had the lowest median expression level and was found to target intronic regions in the SIK2 gene (not shown) and was therefore excluded from analysis. Probe set 1556056_at had log2 expression values below 6 in all samples used and was excluded from further analysis. The remaining two probes had median log2 expression values above 6 and were used for further analysis. B) A Dot plot showing the correlation between the log2 expression values of microarray SIK2 expression and the QPCR data of 13 samples normalized to SIK2 expression in SKOv3 cells. C) Log2 expression data for SIK2 probe "213221_s_at" in paclitaxel resistant and sensitive patients from the paclitaxel arm of the CTCR-OV01 study and in carboplatin resistant and sensitive patients from the carboplatin arm of the study.
shows the correlation between replicates in the screen. Table S1 (excel file) reports the mean ploidy indices for each gene in the screen. Table S2 (excel file) reports the mean ploidy indices, gene names and accession numbers of the 25 identified hits from the screen. Table S3 (excel file) reports the sequences of all siRNAs used in the screen. Figure S4 describes the centrosome engagement/disengagement cycle in SKOv3 cells and provides further controls to support the notion that C-Nap1 is a target for phosphorylation by SIK2 in the centrosome. Figure S7 shows the paradoxical effect of reducing early paclitaxel-induced apoptosis. Table S4 reports the coefficients of correlations between each of the proteins measured by Reverse Phase Protein Arrays and the magnitude of inhibition of proliferation of ovarian cancer cells following KD of SIK2 using three different siRNAs in three ovarian cancer cell lines. No associated supplemental items. A)-The 779 siRNA pools used in the screen were divided into three plates (320 pools for plates 1 and 2 and 139 pools in plate 3) and three replicates were used for each plate. Shown in the lower diagonal of each plot are dot plots representing the correlation between the ploidy indices for each pair of the three replicates used per plate. The corresponding Pearson correlation coefficient for each pair is shown in the upper diagonal of each plot. Although replicate 3 in the first plate shows lower than expected correlation with other replicates, its inclusion in the analysis has not significantly changed the cut-off for this plate as the median of all three replicates was chosen for calculating the cut-off rather than the mean. A) The log2 expression levels of the 4 affymetrix probe sets (platform U 133A Plus 2.0 ) representing SIK2 in 229 ovarian cancers are shown. Probe set 215752_at had the lowest median expression level and was found to target intronic regions in the SIK2 gene (not shown) and was therefore excluded from analysis. Probe set 1556056_at had log2 expression values below 6 in all samples used and was excluded from further analysis. The remaining two probes had median log2 expression values above 6 and were used for further analysis. B) A Dot plot showing the correlation between the log2 expression values of microarray SIK2 expression and the QPCR data of 13 samples normalized to SIK2 expression in SKOv3 cells. C) Log2 expression data for SIK2 probe "213221_s_at" in paclitaxel resistant and sensitive patients from the paclitaxel arm of the CTCR-OV01 study and in carboplatin resistant and sensitive patients from the carboplatin arm of the study.
Supplemental Figures
Paclitaxel resistant patients have significantly higher SIK2 expression compared to paclitaxel sensitive patients. No significant difference was observed for SIK2 expression between carboplatin resistant and sensitive patients. Note that expression profiling from the OV01 study was performed using the affymetrix U133A2 platform that contains only two probe sets for SIK2, the intronic 215752_at, which has been excluded, and 213321_s_at, which is shown here. Horizontal bars represent mean values of the indicated subgroups. from the centrosomes following preincubation with recombinant SIK2 (rSIK2) but not Histone H1. Also note that the γ-tubulin signal has not changed following antibody incubation with any of the two proteins. C) SKOv3 cells were transfected with either non-targeting control siRNA or siRNA targeting SIK2 on cover slips for 48 hours and then fixed and stained for IF using the indicated antibodies to show lack of SIK2 localization in the centrosomes following SIK2 KD. Z-stack images were obtained from at least 8 random fields per cover slip and a compressed image was derived and the percentage of cells showing centrosome SIK2 staining was calculated. Shown is the mean (± s.e.m.) of the percentage of cells with no detectable SIK2 signal. D) Hela cells stably expressing the centriole marker Centrin tagged with GFP were fixed and stained using anti-SIK2 antibody. Note pericentriolar localization of SIK2. Arrows indicate the magnified centrosomes in the inset (or subset) images. Scale bars, 5 μm. E)-SKOv3 cells were transfected on cover slips with a plasmid expressing untagged SIK2 and cells were fixed and stained with the indicated antibodies. Note the increase in intensity of centrosome SIK2 in transfected (II) compared to untransfected (I) cells. F-G) SKOv3 cells transfected in 384 well plates with either empty vector (10 wells) or untagged SIK2-expressing plasmid (10 wells) then fixed and stained using anti-γ-tubulin and anti-SIK2 antibodies and Hoechst stain. Automated microscopy was used to obtain 10 images per stain per well and the signal intensity and area measurements were extracted using the In Cell analyzer software for nuclei, γ-tubulin in centrosomes, cytoplasmic SIK2 and centrosome SIK2 referenced by γ-tubulin staining (see Supplementary experimental procedures for details). In F and G, the log2 cytoplasmic intensity of SIK2 is plotted against the log2 nuclear intensity. Note the effect of transfection on the increasing cytoplasmic SIK2 intensity causing a shift to the right in intensity values. A cutoff of 6 (identified by gating the mock-transfected cells in F) was used to identify SIK2 transfected cells in G. H) SIK2 centrosome intensity was estimated in SIK2 transfected cells identified in C by referencing to γ-tubulin staining. Shown is the mean (± s.e.m.) of intensity values of SIK2 in the cytoplasm and the centrosomes. SKOv3 cells were transfected on cover slips with either empty vector (A-E) or SIK2 expression plasmid (F-G) then fixed and stained after 24 hours using the indicated antibodies. The earliest evidence of disengagement of the parent and daughter centrioles in SKOv3 cells occurs in late cytokinesis (C). At this stage, there are two gamma-tubulin spots each containing one centriole spot in each of the daughter cells. The two centrioles are within nm distances from each other. This is in contrast to prophase and metaphase (A and B) where there are two gamma-tubulin spots each containing two centriole spots. In these phases the centrosomes are widely (>2 μm) separated to form the spindle poles. Therefore, even at the earliest evidence of disengagement, gamma tubulin and centriole spots remain within nm distances from each other in this cell type. In interphase (D and E), gamma-tubulin spots either contain one centriole (presumably in G1) or two centrioles (presumably S/G2). In any case, the percentage of cells showing separation of gamma tubulin spots, or centriole spots, to more than 2 μm apart is <1%. Thus, failure of reengagement following disengagement is unlikely to explain the high percentage of centrosome splitting (examples in reading frame of SIK2 or empty vector control for 24 hours followed by transfection with siRNA targeting the 3`untranslated region (3`UTR) of SIK2. The bar plot shows the mean ± s.e.m of the distance from the nucleus to the centrosomes in microns. D) Cells were plated on cover slips until they were ~80% confluent then transfected with either control or SIK2 siRNA as indicated for 48 hr then a scratch was induced and cells were followed by light microscopy every hour until they were oriented towards the wound. Cells were then fixed and stained. A)-SKOv3 cells were fixed and stained using the indicated antibodies to show that PRKAR2A is present in the centrosome in interphase cells (I, arrow) but is displaced from the centrosomes early in prophase (P, double arrow heads). B-F) SKOv3 cells were plated in 384-well plate in 22 replicate wells per condition and were fixed and stained using the indicated antibodies in B. Automated microscopy was used to collect 8 images for each of the 4 indicated stains per well (32 images per well). The In Cell analyzer software was used for segmentation to extract pixel intensity values for the nucleus using two channels (Hoechst and phospho histone H3 [phH3]) and the centrosomes using two channels (γ-tubulin and either PRKAR2A or SIK2) as described in detail in Supplementary experimental procedures.
In C the mean ratio ± s.e.m between the centrosome pixel intensity value and the median cytoplasmic pixel intensity value for each of the indicated proteins is presented. In D the Integrated nuclear intensity values were used to generate a cell cycle histogram that was used to identify cells in G1 or G2/M. In E the population of mitotic cells were identified as those that were positive for phH3 staining. In The catalogue numbers and sequences of the siRNAs used are listed in Table S3 . siControl non-targeting siRNA number 4 (Dharmacon) was used as a transfection control in all experiments. The sequences of other siRNAs (Dharmacon) used are shown in the table below.
siRNA sequences
For the purpose of the screen, the first three columns of every plate were reserved for transfection controls as follows; siControl and siCDK5 as negative controls (siRNAs that
should not lead to tetraploidy), siTOX (Dharmacon) as control for transfection efficiency and cells only (number of wells = 8, 8, 8, 24, respectively).
Plasmid transfections were mostly conducted on glass cover slips in 24-well plates using 0.8 μg of plasmid DNA mixed with 1 μl of Lipofectamine 2000 (invitrogen) and 100 μl of Optimem medium (Invitrogen) for 20 minutes in a well of 24 well plate and overlaid with 400 μl of cell suspension (50,000 cells) in antibiotic-free medium. For other types of plates, the volumes were scaled up or down depending on the size of the well to maintain the above ratios.
Knockdown of the SIK2 orthologue in Drosophila Double stranded RNA synthesis cDNA Drosophila clone CG4290 which encodes the orthologue of SIK2 in Drosophila was used to amplify a gene fragment that is ~500bp in length using the following oligonucleotides;
forward: 5'-TAATACGACTCACTATAGGGAGAGCAGTCAGAGATGCAGGAGCAGGAA -3'
and reverse 5'-TAATACGACTCACTATAGGGAGAATCGCGCCAGGCATTCCAGCTCAAA -3' (Cyclacel's Polgen® Division collection). The purified PCR product also contained T7
promoter sequences for subsequent in vitro transcription (RiboMAX System-Promega). The single RNA strands were annealed at 72°C for 10 minutes for the production of dsRNA.
Electrophoresis in 1% agarose gel was performed to ensure the presence of a single band and quantification of dsRNA was done using spectrophotometer analysis.
Drosophila cell culture and RNA interference (RNAi)
Drosophila S2 Dmel strain (Invitrogen) were cultured in Express 5 Medium (GIBCO), supplemented with Glutamine (GIBCO) and antibiotics, at 25˚C. These cells have been adapted to grow in serum free medium. 1x10 6 cells were plated in a six well plate overnight before transfection. 20 μg of dsRNA with 20ml of TRANSFAST (Promega) and 1 ml of medium were mixed for 15 minutes and overlaid on the cells for 1hr at 25˚C. After this 3 ml of complete Express 5 medium were added to the cells and incubated for 72 hr. At least three independent experiments were performed.
Immunofluorescence for Drosophila cells
Cells were harvested 72 hours after transfection, plated on glass cover slips for 1 hour then fixed with in PHEM buffer (60mM PEPES, 25 mM HEPES, 10 mM EGTA, 4 mM MgCl2) with 4% paraforlmadehyde. Cells were permeabilized in PBS with 1% Triton X-100 and 3%BSA
followed by 3 washes in PBSTB (PBS 1x with 0.1% Triton X-100 and 1%BSA). Antibodies were used for immunostaining with an overnight incubation at 4°C. The day after the cover slips were washed 3 times with PBSTB and then incubated 2 hours with the secondary antibody in PBSTB. DNA was stained using DAPI and Vectashield mounting medium H-1200 (Vector Laboratories) was used at the end before microscopy analysis. Images were collected using an inverted Zeiss Axiovert 200M microscope (Zeiss).
Flow Cytometry
Cells were trypsinized and fixed with 4% paraformaldehyde for 3 min followed by 70% ethanol at -20°C for at least 1 h. The cells were stained using propidium iodide (Sigma-Aldrich), processed using an LSR II flow cytometer (BD Bioscience), and analyzed using the FACSDiva software (BD Bioscience) to obtain a cell cycle histogram. To estimate the mitotic index, the cells were fixed as described above for the cell cycle analysis and incubated with an anti-phospho-histone H3 antibody (Cell Signaling Technologies). The primary antibody was detected using an Alexa-488-tagged secondary antibody.
Immune-staining microscopy techniques, image acquisition and image analysis
Automated image acquisition, segmentation and analysis (high content analysis)
For performing the screen, SKOv3 cells were transfected using siRNAs in individual wells of black 384-well plates (Greiner, 1750 cells per well) for 48 hr then fixed using 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 3 to 5 min. The cells were washed to remove PFA and were incubated in absolute ethanol at -20°C for at least 1 h before being washed with Tris-buffered saline, 0.04% SDS (Sigma), and 0.2% Triton X-100
(Sigma-Aldrich). Blocking was performed using 1.5% bovine serum albumin in Tris-buffered saline. Nuclear DNA was stained using Hoechst 33258 dye (Invitrogen). Eight images were collected per well using the In Cell Analyzer 1000 (GE Healthcare) with a Nikon 20X PlanFluo lens (Nikon), numerical aperture of 0.45, refractive index of 1 and a focal length of 10,000, pixel width and height; 0.323 and a linear type of 7 μm. A binning value of 1X1 and a gain value of 2 were used to generate the images (1392 X 1040). The excitation wavelength of 360 nm and emission of 535 nM were used with an exposure time of 200 ms and an adjustable offset value, typically at -9.2 μm. The images were analyzed using the In Cell Investigator (GE Healthcare) using a multi-target analysis protocol and a top-hat segmentation method specifying a minimum nuclear size of 50 μm 2 and a sensitivity for detecting pixel clusters of 82%. Within each of the identified features (nuclei) following automated segmentation, the mean density value of the pixels contained within a feature and the area of each feature (nucleus) were estimated. The Integrated nuclear intensity (INI) values (mean nuclear pixel intensity X nuclear area) were used to generate cell cycle histograms.
For quantification of cytoplasmic and centrosome SIK2 ( Figure S3F -H), cells were transfected in 384 well plates using untagged SIK2 and lipofectamine 2000 as described above for 24 hr then fixed and stained using anti-SIK2 mouse antibody (Biolegend) and anti-γ-tubulin rabbit antibody (Sigma). These antibodies were revealed using Alexa-594-conjugated anti-mouse and Alexa-488-conjugated anti-rabbit antibody. For detecting the fluorescence signals, the appropriate excitation and emission filters were used (excitation/emission of 565/620 nm for Alexa-594 and 480/535 nm for Alexa-488) with a typical exposure time of 600 ms and an offset of -4.3 μm for Alexa-594 and 600 ms and -0.8 μm for Alexa-488. A multi-target analysis protocol was used for segmentation. Cytoplasmic SIK2 pixel intensity was extracted using a top-hat segmentation method specifying a minimum cell area of 100 μm 2 and sensitivity for detecting pixel clusters of 74%. Centrosome organelles were segmented in the Alexa-488 channel (γ-tubulin) using a multiscale top-hat protocol with a minimum diameter of 1 μm and maximum of 5 μm with 3 top-hat transformations per image for detecting centrosomes of different sizes, sensitivity of 70% to detect pixel clusters relative to background and a sensitivity range of 1.3 for the ratio of organelle to local background intensity. The organelles were searched for in the entire cell area with no smart masking (no overlap between the cell and the surrounding). The areas of the centrosome organelles in the Alexa-488 channel (γ-tubulin) were used as references for estimating the pixel intensity value of SIK2 in the centrosome in the Alexa-594 channel. For estimating the centrosome intensity of C-Nap1
( Figure 4H-J) , the same technique and parameters were used as described for γ-tubulin following staining using rabbit anti-C-Nap1 antibody and mouse anti-SIK2 antibody and Alexa-594 were similar to the above. In addition, a fourth channel was used for Alexa-647 staining using excitation at 620 nm, emission at 700 nm, typical exposure for 600 ms and a typical offset of 0.6 μm. Nuclear segmentation was similar to that described earlier. The nuclear area in the nuclear channel was used as references for estimation of pixel intensity values from the same areas in the Alexa-647 channel to estimate the intensity of phosphohistone H3 staining. Segmentation of centrosome organelles was done using the γ-tubulin channel as described above.
Immunofluorescence and confocal microscopy Subconfluent cells growing on cover slips were fixed immediately using 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 3 to 5 min. Cells were washed to remove the PFA and were incubated in absolute ethanol at -20°C for at least 1 hr before being washed with Tris-buffered saline, 0.04% SDS (Sigma), and 0.2% Triton X-100 (Sigma-Aldrich).
Blocking was performed using 1.5% bovine serum albumin in Tris-buffered saline. Primary antibodies (Sigma-Aldrich) were incubated at a 1:100 dilution in blocking solution for 1 hr at room temperature then washed three times using the washing buffer. The primary antibodies were detected using Alexa-488-or Alexa-594-conjugated antibodies (Invitrogen). Nuclear DNA was stained using Dapi. Images were collected using an Olympus FV1000 microscope using 60 X or 100 X images. For staining samples from mouse xenografts 10 μm thick frozensectioned tissue samples on uncoated slides were processed as above.
Immunohistochemistry 10 μm thick tissue sections were cut from paraffin embedded blocks of tumour samples and slides were deparaffinized in Xylene, graded alcohol and finally water. Epitope retrieval was performed using Rodent Decloaker (Biocare) at 95 ˚C for 30 min and washed in TBS then blocked using the Rodent block buffer (Biocare) for 30 minutes and incubated with mouse anti-SIK2 antibody (1:100 dilution) overnight then washed and incubated with anti-mouse-HRP secondary antibody for one hr then washed and incubated with Betazoid DAB chromogen (Biocare).
Estimation of the percentage of cells with centrosome splitting (CS):
SKOv3 cells were transfected on cover slips using the appropriate myc/flag tagged plasmid for 24 hr then fixed and stained using anti-myc and anti-γ-tubulin antibodies which were revealed using Alexa-488 and Alexa-594 antibodies of the appropriate species. Images were obtained using confocal microscopy (Olympus FluoView 500 or Olympus Fluo View 1000, Olympus, Inc., Melville, NY).
The estimation of the percentage of cells with splitting of the centrosomes occurred in two phase; A) training phase (counting of CS on printed images): in which fields were randomly selected for imaging and the focus adjusted using the nuclear channel to avoid the bias of selecting fields with split centrosomes. Z stack images were obtained (~6 images per field) and a projection image was derived to represent each field. Images were then printed including scale bar representing 10 μm and the number of cells in which the centrosomes ≥ 2 μm apart (as measured by hand using a ruler) were counted and the percentage in relation to the total number of cells in the field was identified. For empty vector transfections up to 6 fields were selected per experiment. For plasmid transfections, 50 fields were randomly selected to ensure the inclusion of adequate number of myc-positive cells in the analysis. B)
post-training phase (direct counting using the microscope): In this phase the number of cells with split centrosomes were counted by subjective direct estimation without image capturing or printing. Cells with borderline split of the centrosomes were image captured and distance between centrosomes was measured using the Fluoview software (Olympus, Inc).
For estimation of CS following depletion of PRKAR2A or AKAP450, cells were stained using anti-γ-tubulin and anti-phospho-histone H3 and Dapi. The addition of anti-phospho-histone H3
was to ensure the identification and exclusion of prophase cells from the analysis as centrosomes are typically split in this phase irrespective to genetic knockdown.
Nuclear-centrosome uncoupling
Cancer cells were transfected with siControl or SIK2 siRNAs as above on cover slips for 48 hours then fixed and stained using anti-alpha tubulin antibody and anti-γ-tubulin antibody. Zstack images were acquired and a projection image of the stack was obtained and printed. At (Calbiochem) and R63 rabbit anti-C-Nap1 antibody was a kind gift from Dr Eric A Nigg's Laboratory. Chicken anti-dplp antibody was made as previously described (Rodrigues-Martins et al., 2007) .
All reagents were obtained from Sigma unless otherwise indicated.
Statistical analysis:
Analysis of data for the screen from individual cells (n~2 million) was automated using the R For validation of the screen results individual siRNAs were used for knockdown in 384-well plates using the same method as above. Histograms were generated as above and tetraploid 
In vitro cytotoxicity assays
Proliferation assays
To measure cell proliferation by crystal violet staining, 5000 cells were transfected in 96-well plates as above for 24 hours then were treated with paclitaxel (Sigma-Aldrich), or diluent only for 72 h. The cells were fixed using 1% glutaraldehyde and stained using 0.5% crystal violet in 20% methanol for 1 h before being thoroughly washed with water. The dye was solubilized using 100 μL of Sorenson's buffer (0.9% sodium citrate, 0.02 N HCl, and 45% ethanol), and the light absorbance was measured at 540 nm.
The 50% growth inhibitory concentration (GI 50) was estimated using the following formula: 100 x (T -T0)/(C -T0) = 50, where T is the optical density (OD) value after drug treatment, T0 is the OD value at time 0, and C is the OD value for the diluent treatment (Monks et al., 1991) . Time 0 was defined as the day the drug was administered. For estimation of T0 separate plates were used for transfection and fixed and stained after 24 hours as described above. The OD values for each drug concentration was normalized using the formula 100 x (T -T0)/(C -T0) and normalized values were used to fit a least squares curve using Graphpad Prism 5 software (GraphPad Software, Inc.) utilizing a fixed top value of 100 and a fixed bottom value of 0 for each curve and the concentration causing 50% inhibition was estimated from the fitted curve.
Caspase 3/7 assays SKOv3 cells were reverse transfected using the indicated siRNAs for 48 hr in 384-well plates followed by the addition of paclitaxel or diluent to reach the final indicated concentrations.
Caspase 3/7 activity were estimated 48 hr following treatment by adding equal volume of the Caspase-Glo 3/7 Assay reagent (Promega). Luminescence was read following 1 hr of incubation using a luminescence plate reader.
Measuring intracellular ATP content
This was performed using CellTiter glo kit (Promega) according to the manufacturer's instructions and as described in Figure S6F .
Translational studies

Clinical studies
For examining the association between SIK2 expression and outcome (overall survival and progression free survival) patients (n = 227) with high grade serous ovarian cancers were and EOS-KI-R, 5'-GCTGAGACTTATCGATTATCATTATTGCCACCTCCGTCTTGGT-3'. The resulting mutant was confirmed by sequencing using the following primers; EOS-KI-SEQ-F, 5'-ATGGTCATGGCGGATGGC-3' and EOS-KI-SEQ-R, 5'-CATATTCTGTCACAAGG-3'. The GFP-C-Nap1 and myc-C-Nap1 expression plasmids were kind gifts from Dr Erich A. Nigg (Fry et al., 1998; Mayor et al., 2002) .
Expression vectors for C-Nap1 c-terminal protein (C-Nap1-ct). The open reading frame (ORF) encoding the c-terminal C-Nap1 protein from amino acid 1982 to amino acid 2442 was amplified from myc-tagged CNap1 plasmid pBSmyc:2-6 which was a kind gift from Dr E Nigg (Fry et al., 1998) using Accuprime polymerase (Invitrogen) and primers containing attB flanking sequences for Gateway® Technology cloning system, AF52Nterfor2;
GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCAGCATCTCCTCGAGCAGG and, AF52Nterev;
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACTACCTGGAGGCGGCTTGGGTAGTG.
The amplified product was purified and introduced into a pDONR221 plasmid (Invitrogen) using recombination according to manufacturer's instructions and the resulting vector was sequenced. Expression vectors of the protein were produced using pDest15 (Invitrogen) for GST N-terminal fusion or pNPE1 for ProteinA N-terminal fusion.
GST purification
For GST N-terminal fusion protein the expression vector was transformed in BL21(DE3)pLysS bacterial strain (Invitrogen). A single colony was grown at 37°C before induction of expression using 0.5 mM Isopropyl--D-thio-galactoside (IPTG) followed by growing cells at 30°C for 5 hours. Cells were centrifuged for 10 minutes at 6000 rpm and the pellet was resuspended in 5ml Lysis Buffer (20mM Hepes, 500mM NaCl, 1 mM EDTA, 1mM DTT, 2% Sarkosyl detergent and protease inhibitor mix) and was sonicated 3 times for 30 seconds.
The cell extract was incubated for 20 minutes at 4°C on a tube rotator and was centrifuged 20 minutes at 4°C at 10,000 rpm. The supernatant was transferred in a fresh tube and another 5 ml of Lysis Buffer plus 4% Triton X-100 were added. The cell extract was centrifuged again for 20 minutes at 4°C at 10,000 rpm and mixed and incubated for 2 hr at 4°C on a tube rotator with one ml of Glutathione Sepharose 4B (GE Healthcare) which was pre-washed with 10 ml wash buffer (20mM Hepes, 100mM NaCl, 1 mM EDTA, 1mM DTT, 0.1% Triton X-100 and protease inhibitor mix). Beads were centrifuged and the supernatant cell extract recovered.
The beads were washed 3 times with 10 ml Wash Buffer (20mM Hepes, 1 M NaCl, 1 mM EDTA, 1mM DTT, 0.1% Triton X-100 and protease inhibitor mix) and twice with 10 ml Wash Buffer 100mM NaCl (20mM Hepes, 100mM NaCl, 1 mM EDTA, 1mM DTT, 0.1% Triton X-100 and protease inhibitor mix). Finally the beads were washed once with 10ml of PBS 1X and then resuspended in two mls of PBS 1X.
In vitro kinase assays:
In vitro kinase assays were performed using recombinant according to the manufacturer's instructions, GST-C-Nap1-ct and either ATP (SignalChem) or -32 p-ATP, 3000Ci/mmol 10mCi/ml EasyTide Lead (PerkinElmer). In brief, 100 ng of GST-SIK2
was mixed with 1-5 μg of GST-C-Nap1-ct or GST and ATP at final concentration of 100 μM in kinase assay buffer I (SignalChem, 25 mM MOPS, pH7.2, 12.5mM -glycerol-phosphate, 25mM MgCl2, 5mM EGTA, 2mM EDTA, 0.25mM DTT) and incubated at 30 °C for 20 minutes before the reaction was terminated using 2X sample loading buffer and incubated at 95 °C for 5 minutes.
Mass Spectroscopy:
LC-MS/MS experiments were performed using an Eksigent NanoLC-1D Plus (Eksigent Technologies, Dublin, CA) HPLC system and an LTQ Orbitrap mass spectrometer (ThermoFisher, Waltham, MA). Separation of peptides was performed by reverse-phase chromatography using at a flow rate of 300 nL/min and an LC-Packings (Dionex, Sunnyvale, CA) PepMap 100 column (C18, 75 mM i.d. x 150 mm, 3 mM particle size). Peptides were loaded onto a precolumn (Dionex Acclaim PepMap 100 C18, 5 mM particle size, 100A, 300 mM i.d x 5mm) from the autosampler with 0.1% formic acid for 5 minutes at a flow rate of 10 mL/min. The ten port valve was then switched to allow elution of peptides from the precolumn onto the analytical column. Solvent A was water + 0.1% formic acid and solvent B was acetonitrile + 0.1% formic acid. The gradient employed was 5-50% B in 40 minutes. The LC eluant was sprayed into the mass spectrometer by means of a New Objective nanospray source. All m/z values of eluting ions were measured in the Orbitrap mass analyzer, set at a resolution of 7500. Peptide ions with charge states of 2+ and 3+ were then isolated and fragmented in the LTQ linear ion trap by collision-induced dissociation and MS/MS spectra were acquired. Post-run, the data was processed using Bioworks Browser (version 3.3.1 SP1, ThermoFisher). Briefly, all ms/ms data were converted to dta (text) files using the Sequest Batch Search tool (within Bioworks). The dta files were converted to a single mgf file using a SSH script in the SSH Secure Shell Client program (Version 3.2.9 Build 283, SSH Communications Corp.). These combined files were then submitted to the Mascot search algorithm (Matrix Science, London UK) and searched against the NCBI database, using a fixed modification of carbamidomethyl and variable modifications of oxidation (M) and phosphorylation (S,T and Y). The MS/MS spectra corresponding to the phosphopeptides were examined and the phosphorylation sites were manually verified.
Reverse phase protein arrays (RPPA):
RPPA was performed as previously described (Lu et al., 2008) . Cell lysates from cells were adjusted for protein concentrations, denatured with SDS, and serial diluted (5 dilutions) to define the linear range of each antigen-antibody reaction. Lysates were spotted onto nitrocellulose-coated slides (Whatman) with a G3 microarrayer (Genomic Solutions) and probed with antibodies. Signals were captured by tyramide dye deposition (CSA System; DAKO). Slides were scanned on a flatbed scanner to produce 16-bit tiff images and spots were segmented to determine pixel intensities using the quantitative software MicroVigene specifically developed for this approach. Relative protein levels for each sample were determined by interpolation of each dilution curves from the "standard curve" (supercurve)
individual for each slide that was derived by using an R script. All the data points were normalized for protein loading and transformed to linear values. Raw data was presented as a fraction relative to raw data derived from lysates from cells transfected with non-targeting siRNAs.
Western blotting:
The mass of individual aliquots of cell lysates prepared in RIPA buffer was estimated using the Pierce BCA protein assay kit (Thermoscientific) and lysate volumes containing equal protein mass were resolved using SDS-polyacrylamide gel electrophoresis, transferred to Immobilon-P membranes (Millipore) and probed with primary antibody at the recommended dilutions followed by the relevant secondary antibodies conjugated with horseradish peroxidase in a 1:2000 dilution. After washing, proteins were detected by chemiluminescence (GE/Amersham). Experiments involving Immunoblotting of full length C-Nap1 were performed as above but lysates were resolved using Tris-Acetate 3-8% gels (Invitrogen) according to the manufacturer's instructions and transfer was performed using the I-Blot transfer system (Invitrogen) over 7 minutes and 20 seconds to nitrocellulose membranes.
Immunoprecipitation.
SKOv3 cells (1.0x10 6 ) were plated onto 100 mm culture dishes. Cells were lysed with IP lysate buffer (50mM Hepes, pH7.0 / 150mM NaCl / 1.5mM MgCl / 1mM EGTA / 100mM NaF / 10mM sodium pyrophosphate / 10% Glycerol / 1% Triton X-1000 / 1mM PMSF / 1mM Na 3 VO 4 / 10μg/ml Leupeptin / 10μg Aprotinin). For immunoprecipitation, 2 μg of anti-SIK2 or anti-γ-tubulin antibody was added to 2 mg cell lysate. After overnight incubation at 4 o C, protein G beads (Amersham, Uppsla, Sweden) were added and incubated for 1.5 hrs at 4 o C. After washing three times with IP wash buffer (0.5% Triton X-100 / 0.2% NP40 / 150mM NaCl / 10mM Tris, pH7.4 / 1mM EDTA / 1mM EGTA / 1mM Na3VO4 / 1mM PMSF) and three times with PBS, 35μl of 2X sample buffer was added and western blots were performed as described above. A similar protocol was used for immunoprecipitation of C-Nap1.
For immunoprecipitation of protein A tagged C-Nap1-ct, lysates were incubated with Dynabeads that were pre-conjugated with rabbit IgG (MP Biochemicals) overnight at 4 o C.
Tubes containing the above mix were then placed in a magnetic rack till the beads accumulated to the the side of the tube and the supernatant was cleared. The beads were then washed five times as above and the immunoprecipitates were eluted using 250 μl of elution buffer (0.5 M NH4OH, 0.5 mM EDTA) and the eluates were dessicated using vacuum centrifugation till dryness. The pellets were then re-suspended in 25 μl of Laemmli buffer followed by western blotting.
In vivo experiments in mice
Female nude mice of approximately 12 weeks of age were inoculated with ovarian cancer cell lines (HeyA8 or SKOV3ip1) into the peritoneal cavity. HeyA8 and SKOV3ip1 cells were trypsinized, washed and resuspended in Hanks' balanced salt solution (Gibco, Carlsbad, CA) and injected into mice (HeyA8: 5 × 10 5 cells/animal, SKOV3ip1: 1.0 × 10 6 cells/animal) as previously described (Shahzad et al., 2009) . After 1 week, treatment was initiated according to the following groups: 1) control non-silencing siRNA, 2) paclitaxel, 3) SIK2 siRNA-DOPC, 4) combination of paclitaxel and SIK2 siRNA-DOPC. SiRNA was incorporated in DOPCnanoliposomes and administered intraperitoneally (IP) at a dose of 150 μg/kg per mouse, biweekly. Paclitaxel was administered IP once a week at a dose of 100 μg per mouse for HeyA8 and 75 μg per mouse for SKOV3ip1. Mice were treated for 3-4 weeks and all treatment groups were sacrificed and necropsied when any single group became moribund and assayed for tumor weight. Tumor tissue was fixed in formalin for paraffin embedding, and frozen in optimal cutting temperature (OCT) media to prepare frozen slides, or snap frozen for lysate preparation as described above.
Preparation of liposomal siRNA was performed as previously described (Landen et al., 2005) .
In brief, target specific siRNA's were purchased from Sigma-Aldrich. The lyophilized, DOPC incorporated siRNA was hydrated with PBS, and injected IP twice weekly following our previously published protocols (Landen et al., 2007) at 5.0 μg siRNA/200 μL suspension per animal.
